▪ Recharging aged-CAR with NAD⁺ to boost immunotherapy (Jun 25, 2025)

▪ Disarming myeloid resistance in CAR T therapy (Jun 26, 2025)

▪ A CXCR4 partial agonist improves immunotherapy by targeting immunosuppressive neutrophils and cancer-driven granulopoiesis (Jun 26, 2025)

▪ Association of Epstein-Barr virus genomic alterations with human pathologies (Jun 25, 2025)

▪ Post-transcriptional control of gene expression by β-catenin: expanding the non-canonical ARMoury (Jun 24, 2025)

▪ IRF6 controls Epstein-Barr virus (EBV) lytic reactivation and differentiation in EBV-infected epithelial cells (Jun 25, 2025)

▪ Transcriptional regulation of cuproptosis resistance in cancer therapy (Jun 25, 2025)